» Authors » Dafin Muresanu

Dafin Muresanu

Explore the profile of Dafin Muresanu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 356
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Muresanu D, Verisezan-Rosu O, Jemna N, Benedek I, Rednic J, Vlad I, et al.
Brain Sci . 2024 Oct; 14(10). PMID: 39452000
: Cognitive deficits following ischemic stroke significantly impair quality of life, highlighting the need for effective interventions. This study evaluates the efficacy and safety of extended N-Pep-12 dietary supplementation in...
2.
Stefanescu E, Balea M, Chelaru V, Jemna N, Verisezan Rosu O, Truta A, et al.
Biomedicines . 2024 Aug; 12(8). PMID: 39200143
Background: Ischemic stroke (IS) often leads to cognitive and motor impairments. This study aimed to investigate whether Memory-Guided Saccade Tasks (MGSTs) could be used to assess cognitive function in stroke...
3.
Stefanescu E, Strilciuc S, Chelaru V, Chira D, Muresanu D
J Med Life . 2024 Jul; 17(3):368-374. PMID: 39044929
Chronic pain (CP) significantly impacts quality of life and poses an increasing economic burden on healthcare systems worldwide. This study investigates the relationship between blink rate during saccadic eye movements...
4.
StefSnescu E, Strilciuc S, Chelaru V, Chira D, Muresanu D
J Med Life . 2024 Jul; 17(3):360-367. PMID: 39044921
Parkinson's disease (PD) presents a significant clinical challenge due to its profound motor and cognitive impacts. Early diagnosis is crucial for implementing effective, stage-based treatment strategies. Recently, eye-tracking technology has...
5.
Lavorgna L, Maida E, Reinhard C, Cras P, Reetz K, Molnar M, et al.
Telemed J E Health . 2024 Jul; 30(9):2419-2430. PMID: 38946606
People with rare neurological diseases (RNDs) often experience symptoms related to movement disorders, requiring a multidisciplinary approach, including rehabilitation. Telemedicine applied to rehabilitation and symptom monitoring may be suitable to...
6.
Dobran S, Popa L, Muresanu D
J Med Life . 2024 May; 17(1):1-3. PMID: 38737654
No abstract available.
7.
Dobran S, Gherman A, Muresanu D
J Med Life . 2024 Apr; 16(12):1714-1716. PMID: 38585519
No abstract available.
8.
9.
Dobran S, Gherman A, Muresanu D
J Med Life . 2024 Feb; 16(11):1582-1584. PMID: 38406791
No abstract available.
10.
Andriescu C, Gherman A, Dobran S, Muresanu D
J Med Life . 2024 Feb; 16(11):1579-1581. PMID: 38406778
No abstract available.